IN8bio, Inc. (INAB) Earnings History
Net Loss8 years of earnings data (2018–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
IN8bio, Inc. (INAB) Earnings Overview
As of June 17, 2026, IN8bio, Inc. (INAB) reported trailing twelve-month net income of -$19M, reflecting -678.9% year-over-year growth. The company earned $-0.97 per diluted share over the past four quarters.
Looking at the long-term picture, INAB's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2018.
IN8bio, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including FATE (-$130M net income, -2051.1% margin), ADCT (-$137M net income, -175.3% margin), IMVT (-$506M net income), INAB has comparable earnings metrics. Compare INAB vs FATE →
INAB Earnings vs Peers
Earnings metrics vs comparable public companies
INAB Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$19M | +36.1% | -$20M | $-4.44 | - | - |
| 2024 | -$30M | -1.4% | -$30M | $-0.57 | - | - |
| 2023 | -$30M | -5.2% | -$30M | $-1.00 | - | - |
| 2022 | -$29M | -94.6% | -$29M | $-1.36 | - | - |
| 2021 | -$15M | -71.2% | -$15M | $-0.78 | - | - |
| 2020 | -$9M | -66.7% | -$9M | $-0.53 | - | - |
| 2019 | -$5M | -146.7% | -$5M | $-0.27 | - | - |
| 2018 | -$2M | - | -$2M | $-0.11 | - | - |
Download Data
Export INAB earnings history in CSV or JSON format
Free sign-in required to download data
What if you invested $1,000 in INAB back in 2018?
Total return with dividends reinvested · 8+ years of data
Calculate ReturnsHow much would $100/month in INAB be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs INAB Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationINAB vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowINAB — Frequently Asked Questions
Quick answers to the most common questions about buying INAB stock.
What is INAB earnings per share (EPS)?
INAB trailing twelve-month (TTM) diluted EPS is $-0.97, reflecting -678.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is IN8bio, Inc.'s net income?
IN8bio, Inc. (INAB) trailing twelve-month net income is $-19M as of 2025. Earnings declined -678.9% year-over-year.
Is INAB profitable?
INAB is not currently profitable on a TTM basis, reporting a net loss of $-19M. Net margin is N/A. Investors should monitor for a return to profitability.
What is INAB's earnings growth rate?
INAB compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are INAB's profit margins?
IN8bio, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -92.5%.
Is INAB growing earnings?
INAB earnings are declining — EPS fell -678.9% year-over-year. TTM net income dropped to $-19M. This contrasts with the 5-year CAGR of N/A.
What was INAB's best earnings year?
IN8bio, Inc.'s highest annual net income on record is $-2M, achieved in fiscal year 2018. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were INAB's earnings last quarter?
INAB's most recent reported quarter was Q1 2026. Net income was $-5M with diluted EPS of $-0.26. For a full breakdown of all quarters, see the quarterly earnings table on this page.